|
|
Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management |
Rajeev Thekumpadam Puthenveetil, Debajit Baishya, Sasanka Barua, Debanga Sarma
|
Department of Urology, Gauhati Medical College Hospital, Guwahati, Assam, India |
|
|
Abstract Objective: The prevalence of benign prostatic hyperplasia (BPH) rapidly increases after the 4th decade of life. The combination of tamsulosin and dutasteride is a well established therapy for BPH of≥40 g. Non-invasive urodynamic parameters can predict the outcome of medical therapy in patients with BPH. We aimed to correlate these parameters with treatment responses in BPH patients under medical management. Methods: A prospective study was conducted in the Department of Urology in our hospital from May 2014 to April 2015. A total of 100 patients with BPH≥40 g who fulfilled our inclusion criteria were included. Treatment responses were determined by the International Prostate Symptom Score (IPSS) and uroflowmetry. Transabdominal ultrasonography with Doppler was performed to measure prostate volume, intravesical prostatic protrusion (IPP), detrusor wall thickness (DWT), the prostatic capsular artery resistive index (RI) and prostatic urethral angle (PUA) before and 3 months after combination therapy of tamsulosin and dutasteride. Treatment responses were correlated with non-invasive urodynamic parameters. Results: The IPSS, uroflow, age, prostate volume, RI, IPP, DWT and PUA were correlated before and after treatment. Of the 100 patients, 70 (70%) showed significant improvement and 30 (30%) showed no improvement with therapy. Conclusion: Ultrasound bladder parameters are useful tools for measuring the treatment response in BPH patients. Our study shows that RI and DWT significantly correlate with the treatment response in BPH patients. More importantly, pretreatment values of increased IPP and PUA determines the non-improvement of symptoms in BPH patients. Our study suggests the importance of transabdominal ultrasonography (KUB-P) with Doppler for evaluating treatment responses to medical management.
|
Received: 06 May 2015
Published: 29 October 2015
|
Corresponding Authors:
Rajeev Thekumpadam Puthenveetil
E-mail: guwa1986@gmail.com
|
|
|
[1] |
Barry MJ, Fowler Jr FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-57.
|
[2] |
McConnell JD, Barry MJ, Bruskewitz RC. Benign prostatic hyperplasia: diagnosis and treatment. Clinical practice guideline No. 8. Rockville, MD: U.S. Department of Health and Human Services, Agency for Health Care Policy and Research, Public Health Service; 1994. p. 1-17.
|
[3] |
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-9.
|
[4] |
Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol 1998;159:191-4.
|
[5] |
Onur R, Ozden M, Orhan I, Kalkan A, Semercioz A. Incidence of bacteraemia after urodynamic study. J Hosp Infect 2004;57: 241-4.
|
[6] |
Ozdemir H, Onur R, Bozgeyik Z, Orhan I, Ogras MS, Ogur E. Measuring resistance index in patients with BPH and lower urinary tract symptoms. J Clin Ultrasound 2005;33:176-80.
|
[7] |
Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, Miki T. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Eur Urol 2000;37:436-42.
|
[8] |
Shinbo H, Kurita Y, Takada S, Imanishi T, Otsuka A, Furuse H, et al. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia. Urology 2010; 76:1440-5.
|
[9] |
Galosi AB, Mazzaferro D, Lacetera V, Muzzonigro G, Martino P, Tucci G. Modifications of the bladder wall (organ damage) in patients with bladder outlet obstruction: ultrasound parameters. Arch Italurol 2012;84:263-7.
|
[10] |
Cho KS, Kim J, Choi YD, Kim JH, Hong SJ. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation. Med Hypotheses 2008;70:532-5.
|
[11] |
Cho KS, Kim JH, Kim DJ, Choi YD, Kim JH, Hong SJ. Relationship between prostatic urethral angle and urinary flow rate: its implication in benign prostatic hyperplasia pathogenesis. Urology 2008;71:858-62.
|
[12] |
McNeal JE. The prostate and prostatic urethra: a morphologic synthesis. J Urol 1972;107:1008-16.
|
[13] |
Ku JH, Ko DW, Cho JY, Oh SJ. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms. Urology 2010;75: 1467-71.
|
[14] |
Kuo HC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology 1999;54:90-6.
|
[15] |
Keqin Z, Zhishun X, Jing Z, Haixin W, Dongqing Z, Benkang S. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology 2007;70: 1096-9.
|
[16] |
Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 2003;91:371-4.
|
[1] |
H.Kim Eric,A.Brockman John,L.Andriole Gerald. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 28-32. |
[2] |
Xu Peng,Xu Abai,Chen Binshen,Zheng Shaobo,Xu Yawen,Li Hulin,Shen Haiyan,Liu Chunxiao. Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?[J]. Asian Journal of Urology, 2018, 5(1): 48-54. |
[3] |
Xie Liping,Wang Xiao,Chen Hong,Zheng Xiangyi,Liu Ben,Li Shiqi,Mao Yeqing,Mao Qiqi,Wang Song,Li Jiangfeng,Loch Tillmann. Innovative endoscopic enucleations of the prostate-Xie's Prostate Enucleations[J]. Asian Journal of Urology, 2018, 5(1): 12-16. |
[4] |
Guat Ng Lay. Botulinum toxin and benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 33-36. |
[5] |
Han Jie Lee, Alvin Lee, Hong Hong Huang, Palaniappan Sundaram, Keong Tatt Foo. Patients with small prostates and low-grade intravesical prostatic protrusion——A urodynamic evaluation[J]. Asian Journal of Urology, 2017, 4(4): 247-252. |
[6] |
Farhad Fakhrudin Vasanwala, Michael Yuet Chen Wong, Henry Sun Sien Ho, Keong Tatt Foo. Benign prostatic hyperplasia and male lower urinary symptoms:A guide for family physicians[J]. Asian Journal of Urology, 2017, 4(3): 181-184. |
[7] |
Keong Tatt Foo. Pathophysiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 152-157. |
[8] |
Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158-163. |
[9] |
Kok Bin Lim. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 148-151. |
[10] |
Kok Kit Ng, Foo Cheong Ng. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men[J]. Asian Journal of Urology, 2017, 4(3): 191-194. |
[11] |
Ryan Yu, Jefferson Terry, Mutaz Alnassar, Jorge Demaria. Pediatric fibrous pseudotumor of the tunica vaginalis testis[J]. Asian Journal of Urology, 2016, 3(2): 99-102. |
[12] |
Alvin Lee, Han Jie Lee, Kok Bin Lim, Hong Hong Huang, Henry Ho, Keong Tatt Foo. Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?[J]. Asian Journal of Urology, 2016, 3(1): 39-43. |
[13] |
Cheng Yang, Mushuang Hu, Tongyu Zhu, Wanyuan He. Evaluation of kidney allograft status using novel ultrasonic technologies[J]. Asian Journal of Urology, 2015, 2(3): 142-150. |
[14] |
Bilal Chughtai, Leanna Laor, Claire Dunphy, Alexis Te. Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia (BPH)[J]. Asian Journal of Urology, 2015, 2(2): 102-106. |
[15] |
Michael E. Chua, Patrick P. Tanseco, Jonathan S. Mendoza, Josefino C. Castillo, Marcelino L. Morales Jr, Saturnino L. Luna Jr. Configuration and validation of a novel prostate disease nomogram predicting prostate biopsy outcome: A prospective study correlating clinical indicators among Filipino adult males with elevated PSA level[J]. Asian Journal of Urology, 2015, 2(2): 114-122. |
|
|
|
|